The effect of empagliflozin on cardiovascular outcomes in patients with chronic kidney disease; a systematic review and meta-analysis

Majid Foroutan ^1,2 , Maliheh Yarmohammadi ^1,2 *

Cited by CrossRef: 0

1- Bahardoust M, Rad F, Mousavi S, Shamohammadi M, Haghmoradi M, Ghaffari A. The Effect of Empagliflozin on Renal Outcomes in Patients With Established Cardiovascular Disease: Systematic Review and Meta‐Analysis of Randomised Placebo‐Controlled Trials. Endocrino Diabet & Metabol. 2026;9(3) [Crossref]